Summary

Report Scope
This research report analyzes the global market for pharmaceutical drugs and its competitive landscape through 2029. It covers leading manufacturers of pharmaceutical drugs and the companies providing pharmaceutical services to biopharma and pharmaceutical firms), competitive intelligence and technological advances. The analysis includes recent developments in the product portfolios of major companies, as well as market share and rankings. The regulatory landscape analysis focuses on recent regulations in the U.S., Europe, and Japan. BCC Research estimated market size data for 2023 (base year) and forecast values for 2024 through the end of 2029. This report also examines drivers, restraints, and opportunities in the global market.
Report Includes
- 57 data tables and 152 additional tables
- Evaluation of the current and future market potential of the pharmaceutical industry, featuring a look at the competitive landscape of the 50 leading pharmaceutical manufacturers
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2021-2024, and projected CAGRs through 2029
- Discussion of the opportunities in the pharmaceutical industry, along with an evaluation of the competitive environment, regulatory landscape, and technological trends and advances
- A look at the regulatory and pricing scenarios in the global market, with an emphasis on recently enacted regulations in the U.S., Europe and Japan
- Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Analysis of patent activity, including key granted and published patents
- Descriptive company profiles of the leading pharma manufacturers, including Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Merck & Co. Inc., and F. Hoffmann La Roche Ltd.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Stakeholders Involved in the Innovation Process
Future Perspectives
PESTEL Analysis
Porter's Five Forces Analysis
Supply Chain Analysis
Raw Materials Sourcing
Drug Manufacturing
QC and Compliance
Distribution
Regulatory Approval and Pricing Constraints
Sales and Marketing
Reverse Logistics and Returns
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Rising Healthcare Expenditures
Focus on Rare Diseases and Orphan Drugs
Increasing Prevalence of Chronic Diseases and Aging Populations
Market Restraints
Stringent Regulatory Concerns
Loss of Exclusivity and Genericization
Lack of Oncology Professionals
Market Opportunities
Focus on Health Equity and Accessibility
AI in Oncology
Emerging Markets
Market Challenges
Price Pressures and Market Access
Environmental Impact and Sustainability
Counterfeit Drugs
Chapter 4 Regulatory Landscape
Regulatory Framework
Regulatory Systems for Biopharmaceuticals
U.S.
Europe
Japan
Regulatory Systems for Pharmaceuticals
U.S.
EU Approval Process
Japan Approval Process
India Approval Process
Brazil Approval Process
GMP Compliance
Establishment Registration
Drug Registration and Listing
Local Agent Requirements
Responsibilities of the U.S. Agent
Chapter 5 Emerging Technologies and Developments
Emerging Technologies
Artificial Intelligence (AI) and Machine Learning (ML)
Nanotechnology
3D Printing
Patent Analysis
Takeaways
Chapter 6 Sustainability in the Pharmaceutical Drug Industry: An ESG Perspective
Sustainability in the Pharmaceutical Drugs Industry
Environmental
Social
Governance
Understanding ESG Data
Concluding Remarks from BCC Research
Chapter 7 Competitive Intelligence
Overview
Global Market Shares of Pharmaceutical Drug Companies
Strategies of Major Pharmaceutical Drug Manufacturers
Distribution Networks
Chapter 8 Appendix
Methodology
Abbreviations
Sources
Company Profiles
ABBOTT
ABBVIE INC.
ALNYLAM PHARMACEUTICALS INC.
AMGEN INC.
ARGENX
ASTELLAS PHARMA INC.
ASTRAZENECA
AUROBINDO PHARMA LTD.
BAUSCH HEALTH COMPANIES INC.
BAXTER
BAYER AG
BIOCON
BIOGEN
BIOMARIN
BIONTECH SE
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BRISTOL-MYERS SQUIBB CO.
CHUGAI PHARMACEUTICAL CO. LTD.
CSL
CSPC PHARMACEUTICAL GROUP LTD.
DAIICHI SANKYO CO. LTD.
DIVI'S LABORATORIES LTD.
EISAI CO. LTD.
F. HOFFMANN-LA ROCHE LTD.
GALDERMA
GILEAD SCIENCES INC.
GRIFOLS S.A.
GSK PLC.
H. LUNDBECK A/S
INCYTE
JAZZ PHARMACEUTICALS INC.
JOHNSON & JOHNSON SERVICES INC.
LES LABORATOIRES SERVIER
LILLY
MERCK & CO. INC.
MERCK KGAA
MODERNA INC.
NEUROCRINE BIOSCIENCES INC.
NOVARTIS AG
NOVO NORDISK A/S
OTSUKA HOLDINGS CO. LTD.
PFIZER INC.
REGENERON PHARMACEUTICALS INC.
SANOFI
SINO BIOPHARMACEUTICAL CO. LTD.
SUN PHARMACEUTICAL INDUSTRIES LTD.
TAKEDA PHARMACEUTICAL CO. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
VERTEX PHARMACEUTICALS INC.
VIATRIS INC.
Emerging Players in the Market